A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
Fries
D
D
Division of Nephrology, Paris Sud University, Hospital Bicêtre, Kremlin Bicêtre, France.
Hiesse
C
C
Charpentier
B
B
Lantz
O
O
Bensadoun
H
H
Benoit
G
G
D000206:Actuarial Analysis; D000328:Adult; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D002102:Cadaver; D003524:Cyclosporins / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005602:France / Q000453:epidemiology; D006084:Graft Rejection; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007674:Kidney Diseases / Q000139:chemically induced; D016030:Kidney Transplantation / Q000401:mortality; D008875:Middle Aged; D009926:Organ Preservation; D011241:Prednisone / Q000008:administration & dosage; D015996:Survival Rate
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone